Company and Conference Call Information
There will be a conference call on
Abilify® is a trademark of
Atripla® is a trademark of
Avapro®, Avalide®, and Plavix® are trademarks of Sanofi.
Byetta® and Bydureon®are trademarks of
Erbitux® is a trademark of
Humira® is a trademark of
All other brand names are registered trademarks of the company and/or one of its subsidiaries.
FOR THE THREE MONTHS ENDED |
|(Unaudited, dollars in millions)|
|The following table sets forth worldwide and U.S. reported net sales for selected products. In addition, the table includes, where applicable, the estimated total U.S. prescription change for the retail and mail-order channels for the comparative periods presented for certain of the company's U.S. pharmaceutical products based on third-party data. A significant portion of the company's U.S. pharmaceutical sales is made to wholesalers. Where changes in reported net sales differ from prescription growth, this change in net sales may not reflect underlying prescriber demand.|
For more stories covering the world of technology, please see HispanicBusiness' Tech Channel
© 2013 HispanicBusiness Inc. All Rights Reserved.